Serial studies of serum interleukin-2 in chronic progressive multiple sclerosis patients: occurrence of ‘bursts’ and effect of cyclosporine
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 28 (1) , 9-14
- https://doi.org/10.1016/0165-5728(90)90036-m
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- INTERLEUKIN-2 RECEPTOR LEVELS INDICATING RELAPSE IN MULTIPLE SCLEROSISThe Lancet, 1989
- Correlation of immunological studies and disease progression in chronic progressive multiple sclerosisAnnals of Neurology, 1989
- Interleukin‐2 levels in serum and cerebrospinal fluid of multiple sclerosis patientsAnnals of Neurology, 1988
- Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patientsJournal of Neuroimmunology, 1988
- Elevated Serum Interleukin-2 Levels in Chronic Progressive Multiple SclerosisNew England Journal of Medicine, 1988
- Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Activated T lymphocytes in patients with multiple sclerosis in clinical remissionJournal of the Neurological Sciences, 1987
- Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.Journal of Clinical Investigation, 1986
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983